THE MEDICINES CO has a total of 58 patent applications. It decreased the IP activity by 93.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, Canada and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are WANK RUDOLF, BIOVECTOR THERAPEUTICS and INTERVET INTERNEHSHNL B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Canada | 9 | |
#3 | Brazil | 8 | |
#4 | China | 4 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Australia | 3 | |
#7 | Hungary | 3 | |
#8 | Mexico | 3 | |
#9 | WIPO (World Intellectual Property Organization) | 3 | |
#10 | EAPO (Eurasian Patent Organization) | 2 | |
#11 | Chile | 1 | |
#12 | Hong Kong | 1 | |
#13 | Israel | 1 | |
#14 | Republic of Korea | 1 | |
#15 | Netherlands | 1 | |
#16 | Norway | 1 | |
#17 | New Zealand | 1 | |
#18 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Medical technology | |
#6 | Packaging and shipping | |
#7 | Civil engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Sugars | |
#4 | Enzymes | |
#5 | Microorganisms | |
#6 | Peptides | |
#7 | Fermentation | |
#8 | Medical purpose containers | |
#9 | Containers for goods storage | |
#10 | Shafts |
# | Name | Total Patents |
---|---|---|
#1 | Motheram Rajeshwar | 11 |
#2 | Krishna Gopal | 10 |
#3 | Ding Min | 9 |
#4 | Kallend David | 8 |
#5 | Wijngaard Peter | 8 |
#6 | Rafai Far Adel | 8 |
#7 | Chemburkar Sanjay R | 6 |
#8 | Skerjanec Simona | 6 |
#9 | Knable Carl M | 6 |
#10 | Reamer Douglas M | 6 |
Publication | Filing date | Title |
---|---|---|
KR20190077411A | Preventing Cardiovascular Events Through Protein Reduction Protein Conjugate Enzymes (PCSK9) | |
US2017224662A1 | Aqueous Formulations and Methods of Preparation and Use Thereof | |
US2016206687A1 | Methods for treating bacterial infections using oritavancin and polymyxins | |
US2014107032A1 | Methods of treating, reducing the incidence of, and/or preventing ischemic events | |
US2013190265A1 | Methods of treating, reducing the incidence of, and/or preventing ischemic events | |
CA2778880A1 | Methods of treating or preventing stent thrombosis | |
BRPI0917562A2 | pharmaceutical compositions and methods for stabilizing them |